[HTML][HTML] Novel advancements in the management of hepatocellular carcinoma in 2008
New advancements have emerged in the field of hepatocellular carcinoma (HCC) in recent
years. There has been a switch in the type of presentation of HCC in developed countries …
years. There has been a switch in the type of presentation of HCC in developed countries …
the management of hepatocellular carcinoma
R Cabrera, DR Nelson - Alimentary pharmacology & …, 2010 - Wiley Online Library
Aliment Pharmacol Ther 31, 461–476 Summary Background Hepatocellular carcinoma is
the leading cause of death in cirrhosis. A majority of patients present at an advanced stage …
the leading cause of death in cirrhosis. A majority of patients present at an advanced stage …
[HTML][HTML] Hepatocellular carcinoma review: current treatment, and evidence-based medicine
A Raza, GK Sood - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide. Multiple
treatment options are available for HCC including curative resection, liver transplantation …
treatment options are available for HCC including curative resection, liver transplantation …
Molecular targeted therapies in hepatocellular carcinoma: past, present and future
M Stotz, A Gerger, J Haybaeck, T Kiesslich… - Anticancer …, 2015 - ar.iiarjournals.org
Hepatocellular carcinoma (HCC) is an aggressive tumor and the sixth most common form of
cancer worldwide. Surgery is the gold-standard treatment for local disease and often …
cancer worldwide. Surgery is the gold-standard treatment for local disease and often …
[HTML][HTML] Current and future treatment of hepatocellular carcinoma: an updated comprehensive review
S Daher, M Massarwa, AA Benson… - Journal of clinical and …, 2018 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality.
The principal treatment is surgical resection or liver transplantation, depending on whether …
The principal treatment is surgical resection or liver transplantation, depending on whether …
Management of advanced hepatocellular carcinoma in the era of targeted therapy
Systemic chemotherapy has had a disappointing track record in the management of
advanced hepatocellular carcinoma (HCC). Single‐agent doxorubicin produces a response …
advanced hepatocellular carcinoma (HCC). Single‐agent doxorubicin produces a response …
[HTML][HTML] New advances in hepatocellular carcinoma
S Pascual, I Herrera, J Irurzun - World journal of hepatology, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the leading cause of deaths in cirrhotic patients and the
third cause of cancer related deaths. Most HCC are associated with well known underlying …
third cause of cancer related deaths. Most HCC are associated with well known underlying …
[PDF][PDF] Advanced hepatocellular carcinoma. Review of targeted molecular drugs
RCP Alves, D Alves, B Guz, C Matos, M Viana… - Annals of …, 2016 - medigraphic.com
Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world in terms of
incidence, accounting for approximately 630 thousand new cases per year; in addition, HCC …
incidence, accounting for approximately 630 thousand new cases per year; in addition, HCC …
Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?
RS Finn - Clinical Cancer Research, 2010 - AACR
Hepatocellular carcinoma (HCC), once considered an orphan disease in the West, has
become a global health concern. It is the third leading cause of cancer death worldwide, and …
become a global health concern. It is the third leading cause of cancer death worldwide, and …
Hepatocellular carcinoma: clinical frontiers and perspectives
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death and is
currently the main event leading to death in patients with cirrhosis. Evolving information …
currently the main event leading to death in patients with cirrhosis. Evolving information …